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Abstract
Background: The prevalence of hypertension and its contribution to cardiovascular disease risk makes
it imperative to identify factors that may help prevent this disorder. Extensive biological and biochemical
data suggest that plasma ascorbic acid may be such a factor. In this study we examined the association
between plasma ascorbic acid concentration and blood pressure (BP) in young-adult women.
Methods: Participants were 242 Black and White women aged 18–21 yr from the Richmond, CA, cohort
of the National Heart, Lung and Blood Institute Growth and Health Study. We examined the associations
of plasma ascorbic acid with BP at follow-up year 10, and with change in BP during the previous year.
Results: In cross-sectional analysis, plasma ascorbic acid at year 10 was inversely associated with systolic
BP and diastolic BP after adjusting for race, body mass index, education, and dietary intake of fat and
sodium. Persons in the highest one-fourth of the plasma ascorbic acid distribution had 4.66 mmHg lower
systolic BP (95% CI 1.10 to 8.22 mmHg, p = 0.005) and 6.04 mmHg lower diastolic BP (95% CI 2.70 to
9.38 mmHg, p = 0.0002) than those in the lowest one-fourth of the distribution. In analysis of the change
in BP, plasma ascorbic acid was also inversely associated with change in systolic BP and diastolic BP during
the previous year. While diastolic blood pressure among persons in the lowest quartile of plasma ascorbic
acid increased by 5.97 mmHg (95% CI 3.82 to 8.13 mmHg) from year 9 to year 10, those in the highest
quartile of plasma vitamin C increased by only 0.23 mmHg (95% CI -1.90 to +2.36 mmHg) (test for linear
trend: p < 0.0001). A similar effect was seen for change in systolic BP, p = 0.005.
Conclusion: Plasma ascorbic acid was found to be inversely associated with BP and change in BP during
the prior year. The findings suggest the possibility that vitamin C may influence BP in healthy young adults.
Since lower BP in young adulthood may lead to lower BP and decreased incidence of age-associated
vascular events in older adults, further investigation of treatment effects of vitamin C on BP regulation in
young adults is warranted.
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Elevated blood pressure (BP) is a major public health
problem in the United States with almost 60% of Ameri-
can adults having pre-hypertension or hypertension [1].
The disorder is prevalent in all major ethnic groups,
although Blacks are disproportionately affected [1]. As
elevated BP is a strong and independent risk factor for car-
diovascular and renal disease morbidity and mortality [2],
identifying preventive measures is an important public
health goal.
The Dietary Approaches to Stop Hypertension (DASH)
trial demonstrated that diet is an important factor in BP
regulation. In that study, a diet rich in vegetables, fruit,
low-fat dairy foods, and with reduced saturated and total
fat intake significantly reduced systolic BP and diastolic
BP over a period of 8 weeks compared to a control diet [3].
DASH diet constituents believed to contribute to the
observed BP-lowering effect include calcium, magnesium,
potassium, dietary fiber, and the reduced fat content of
the diet [3,4]. The DASH diet is also rich in vitamin C,
another possible contributor to the observed BP effect [5].
Mechanistic studies have demonstrated a role of vitamin
C in maintaining the normal production and biological
activity of endothelium-derived nitric oxide which plays a
role in vascular tone and reactivity [6,7]. Thus, plasma
ascorbic acid concentration should be investigated for its
possible role in lowering or maintaining normal BP.
Numerous cross-sectional studies have observed highly
significant inverse relationships between BP and circulat-
ing ascorbic acid concentration [8-18]. Almost all such
studies have focused on populations that are middle-aged
and older, and intervention research has typically focused
on treatment of those with already elevated blood pres-
sure. However, we hypothesized that an ascorbic acid
association in a young normotensive population might
provide clues to the primary prevention of hypertension.
Examining this relationship in young adults is potentially
important because maintaining healthy BP in healthy
young adults may lead to a lower BP in older adults, and
consequently a lower incidence of age-associated vascular
events [2]. Therefore, we investigated this relationship
among 18–21 year old Black and White women enrolled
in the National Heart, Lung, and Blood Institute (NHLBI)
Growth and Health Study. We hypothesized that plasma
ascorbic acid concentration at the 10th annual follow-up
visit would be inversely associated with BP, and inversely
associated with change in BP during the previous year, in
this population group.
Methods
Participants
In 1985, the NHLBI initiated the Growth and Health
Study, a 10-year longitudinal multicenter study to investi-
gate the development of obesity in Black and White girls
during adolescence, along with its environmental, psy-
chosocial, and cardiovascular disease risk factor corre-
lates. Black and White girls, ages 8 to 11 years, were
recruited from Richmond, CA, Cincinnati, OH, and Wash-
ington, DC areas. Institutional review board approval was
obtained at all participating centers. The parents or guard-
ians of participants gave informed consent for the chil-
dren to participate. Girls were followed annually through
ages 18 to 21 years, with a follow-up rate of 90% at the
10th annual follow-up visit. The sample design, recruit-
ment and selection procedures used for the Growth and
Health Study have been previously described [19]. For this
investigation, plasma ascorbic acid samples were
obtained only from girls in the Richmond, CA cohort at
the 10th annual visit. The blood draw for plasma ascorbic
acid was implemented midway through the annual data
collection period and a total of 335 participants were seen
in the clinic after plasma sample collection was initiated.
Plasma samples were successfully obtained from 242 par-
ticipants (72%), consisting of 155 Blacks and 87 Whites.
The 93 who did not participate in the extra blood draw
were either seen on a day when the ascorbic acid study
staff was not present to take their blood, were pregnant, or
refused the extra procedure.
Data collection
BP
BP measurements were obtained by trained examiners
according to a standard protocol [20]. Participants were
seated with feet resting flat on a surface and the right arm
resting at heart level. Participants were seated for at least 5
minutes before BP measurements were begun. The appro-
priate cuff was selected from 5 cuff sizes and placed
around the upper arm. Using a standard mercury sphyg-
momanometer (Baum Desktop model with V-Lok cuffs),
three consecutive readings were taken using the same arm
and waiting at least 30 seconds between readings. The sec-
ond and third readings were averaged to determine the
mean systolic BP, defined as the onset of the first two con-
secutive beats (first Korotkoff phase), and the mean
diastolic BP, defined as the point at which the sound dis-
appeared (fifth Korotkoff phase). BP was obtained at both
the 9th and 10th annual visits.
Plasma ascorbic acid
Participants were instructed to fast for at least 12 hours
before the blood draw. Plasma ascorbic acid was deter-
mined using the 2,4-dinitrophenylhydrazine method
[21], which has been shown to correlate well with HPLC
methods [22]. Plasma was stabilized with 10% metaphos-
phoric acid, frozen at -70°C within 4 hours of the collec-
tion, and analyzed within six months. Plasma ascorbic
acid was assayed only at the 10th annual visit. Blood stored
from earlier visits could not be used for assaying ascorbicPage 2 of 9
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phoric acid.
Anthropometry
At the 10th annual visit, participants were weighed using
an electronic scale (SECA Alpha 770) in gowns without
shoes. Height was measured using a custom portable sta-
diometer (Creative Health Products, Plymouth, MI). Par-
ticipants wore socks and were positioned with heels
together, toes apart at a 45 degree angle, and head in the
Frankfort horizontal plane. Both weight and height were
measured twice and repeated a third time if values differed
by more than 0.3 kg and 0.5 cm, respectively. Body mass
index (BMI) was calculated as kg/m2.
Socioeconomic and lifestyle variables
Information on socioeconomic and lifestyle variables was
ascertained by questionnaire at the 10th annual visit.
Smoking was assessed by asking how many days partici-
pants smoked in the past 30 days and how many cigarettes
were smoked per day. The number of smoking days/
month was then multiplied by the number of cigarettes/
day to create a continuous variable, cigarettes smoked/
month. Alcohol consumption was assessed in a similar
fashion, with 1 drink being equivalent to 12 oz. (355 mL)
of beer or 6 oz. (177 mL) of wine. The number of hours/
week of television or videos watched was assessed as a
proxy for physical inactivity. Pregnancy history and cur-
rent contraceptive use was also obtained.
Dietary variables
Dietary information at the 10th annual visit was deter-
mined using 3-day dietary records, covering two consecu-
tive weekdays and one weekend day. Participants used
rulers, pictures, and thickness guides to measure and
quantify the amount of food consumed. Dietary records
were reviewed with a dietitian and analyzed for nutrient
composition by the Cincinnati Dietary Center using the
University of Minnesota Nutrition Coordinating Center
database. The method used for estimating nutrient intake
had been previously validated in this population [23]. All
micronutrient intake estimates include amounts provided
by supplements. Estimates of dietary sodium intake were
from food only and no attempt was made to collect infor-
mation on added dietary salt intake.
Statistical analyses
Unpaired two-tailed t-tests and Wilcoxon two-sample
tests were used to compare baseline characteristics of
Black and White study participants. Plasma ascorbic acid
at year 10 was divided into quartiles, and least squares
mean diastolic and systolic BP, adjusted for race, BMI,
education, and intake of fat and sodium, were calculated
for each quartile using analysis of covariance. Change in
BP was calculated as the systolic and diastolic values at
year 10 minus their respective values at year 9, and
adjusted changes were calculated using analysis of covari-
ance; year 9 BP was included as a covariate in the model.
The relationships between plasma ascorbic acid and BP at
the 10th annual visit, as well as between plasma ascorbic
acid at year 10 and change in BP in the previous year, were
also examined as continuous variables using multivaria-
ble linear regression models. The interaction of race and
BMI with the independent variable was assessed using
cross-product terms in the regression models. Annual
household income and education were highly correlated.
However, education explained more of the variance, and
consequently education was used in the models. A
number of other covariates were considered as potential
confounders, including intake of total energy, potassium,
calcium, dietary antioxidants, and fiber, pregnancy his-
tory, use of birth control pills, smoking, alcohol con-
sumption, and number of hours/week of television or
video watching. However, none was statistically signifi-
cant and these variables were not included in the final
models. Statistical analyses were conducted with SAS 9.1.
Results
Descriptive characteristics and comparisons of the total
sample and by race are presented in Table 1. Mean diasto-
lic BP, age, weight, BMI, energy intake, and plasma ascor-
bic acid concentrations did not differ significantly by race.
Black women had higher mean systolic BP, watched more
hours/week of television or videos, consumed more fat/
day, and lived in households with lower incomes as com-
pared to White women. Blacks also smoked significantly
fewer cigarettes, drank less alcohol, and were more likely
to have been pregnant (data not shown.) However, race
did not significantly modify the relationship between
plasma ascorbic acid and BP (interaction terms for systolic
and diastolic BP were p = 0.42 and p = 0.47, respectively).
Therefore, statistical models included all 242 subjects and
were not stratified by race.
For comparison of BP in categories of plasma ascorbic
acid, the plasma ascorbic acid distribution among partici-
pants at visit 10 was divided into fourths. Mean concen-
trations of ascorbic acid, by quartile, were as follows:
Quartile 1: 0.59 mg/dL (SD 0.18 mg/dL); Quartile 2: 1.03
mg/dL (SD 0.10 mg/dL); Quartile 3: 1.36 mg/dL (SD 0.10
mg/dL); and Quartile 4: 1.83 mg/dL (SD 0.34 mg/dL).
(Means in SI units: 33.51 μmol/L, 58.50 μmol/L, 77.25
μmol/L, 103.94 μmol/L for quartiles 1 through 4, respec-
tively.)
In cross-sectional analyses, we examined BP across quar-
tiles of plasma ascorbic acid at the 10th annual visit. There
was a significant inverse linear trend in both systolic BP
(Figure 1) and diastolic BP (Figure 2) across the quartiles
of plasma ascorbic acid concentration (unadjusted p =Page 3 of 9
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quartiles as predictor variables, after adjustment for BMI,
race, education, and dietary fat and sodium intake, these
inverse linear trends remained significant for both systolic
BP and diastolic BP, with substantial differences in BP
across the quartiles. Persons in the upper one-fourth of
the plasma ascorbic acid distribution had 4.66 mmHg
lower systolic BP (95% CI 1.10 to 8.22 mmHg, p = 0.005)
than those in the lower one-fourth of the plasma ascorbic
acid distribution. For diastolic BP, persons in the upper
one-fourth of the plasma ascorbic acid distribution had
6.04 mmHg lower diastolic BP (95% CI 2.70 to 9.38
mmHg, p = 0.0002) than those in the lower quartile of
ascorbic acid. We also performed multiple regression
analysis of ascorbic acid as a continuous variable, with BP
as the dependent variable, plasma ascorbic acid as the pri-
mary predictive variable, and adjusting for BMI, race, edu-
cation, dietary fat and sodium intake. Cross-sectionally, as
plasma ascorbic acid concentration increased by 1 mg/dL
(56.8 μmol/L), systolic BP decreased by 4.1 mmHg (95%
CI -6.6 to -1.7 mmHg) and diastolic BP decreased by 4.0
mmHg (95% -6.4 to -1.7 mmHg).
We also examined the association between plasma ascor-
bic acid concentration at year 10 and change in BP
between years 9 and 10. Change in both systolic BP and
diastolic BP was inversely associated with plasma ascorbic
acid concentration at year 10 (Figure 3) after adjustment
for BMI, race, education, and dietary fat and sodium
intake. Systolic BP increased by 1.40 mmHg (95% CI -
0.76 to +3.57 mmHg) among those in the lowest quartile
of the plasma ascorbic acid distribution, but decreased in
persons in higher quartiles of plasma ascorbic acid (test
for linear trend in change in BP across quartiles of year 10
ascorbic acid: p = 0.005). Diastolic BP increased overall,
but the increase was less with increasing quartiles of
plasma ascorbic acid. While diastolic blood pressure
among persons in the lowest quartile of plasma ascorbic
acid increased by 5.97 mmHg (95% CI 3.82 to 8.13
mmHg) from year 9 to year 10, those in the highest quar-
tile of plasma vitamin C increased by only 0.23 mmHg
(95% CI -1.90 to +2.36 mmHg) (test for linear trend: p <
0.0001). Control for weight change between years 9 and
10 made essentially no difference in these results (data
not shown).
Discussion
We found plasma ascorbic acid concentration to be
inversely associated with systolic and diastolic BP in
young-adult Black and White women, independent of
race, BMI, education, diet, and lifestyle factors. A 1 mg/dL
(56.8 μmol/L) increase in plasma ascorbic acid levels was
associated with 4.1 mmHg lower systolic blood pressure
and 4.0 mmHg lower diastolic blood pressure. Plasma
ascorbic acid levels in this cohort ranged from 0.22 to
3.13 mg/dL (12.5 to 177.8 μmol/L), indicating that a 1
mg/dL change in plasma ascorbic acid level is achievable
in this young population.
Plasma ascorbic acid concentration was also inversely and
significantly associated with change in BP during the pre-
vious year. It is particularly notable that there was very lit-
tle increase in diastolic BP in persons in the highest
quartile of ascorbic acid.
Table 1: Characteristics of 242 young-adult women in the Richmond, CA cohort of the NHLBI Growth and Health Study, 1996–1997.
All
(n = 242)
Blacks
(n = 155)
Whites
(n = 87)
Mean SD Mean SD Mean SD p*
Systolic BP (mmHg) 109.8 10.3 111.1 10.8 107.4 9.0 0.007
Diastolic BP (mmHg) 66.9 9.0 67.4 9.0 66.1 9.0 0.31
Plasma vitamin C (mg/dL)† 1.2 0.5 1.2 0.4 1.2 0.6 0.34
Age (yr) 19.1 0.6 19.2 0.7 19.1 0.6 0.28
Weight (kg) 70.9 19.3 71.2 19.3 70.4 19.3 0.74
BMI (kg/m2) 26.1 6.7 26.4 6.6 25.7 6.9 0.40
Television or video watching 
(hr/wk)
32.0 24.1 39.3 23.9 19.0 18.4 < 0.0001
Household income ($)‡ 20,000–29,999 10,000–19,999 30,000–39,999 < 0.0001
Total energy intake (kcal/d) 1919.6 787.2 1985.8 827.7 1809.9 706.4 0.11
Total fat intake (gm/d) 74.1 36.8 79.3 36.2 65.5 36.2 0.006
Dietary vitamin C intake (mg/d)**
Mean (median, 25th 75th %ile)
121.7
(79.3)
176.6
(38.9, 128.2)
128.1
(80.0)
203.4
(43.4, 126.1)
111.1
(63.5)
120.3
(31.0, 136.5)
0.43
* P-values pertain to comparison between Blacks and Whites.
† Multiply by 56.8 to convert to SI units, μmol/L
‡ Household income values are the categories in which the median fell.
** Values in parentheses represent median (in the Means column) and 25th/75th percentiles (in the Standard Deviations column)Page 4 of 9
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blood pressure associated with plasma ascorbic acid is
consistent with the range of values found in other cross-
sectional studies [8-18]. A review by Ness [18] found that
the blood pressure difference associated with a 50 μmol/L
(0.88 mg/dL) difference in ascorbic acid concentration
ranged from -2.6 to -9.4 mmHg for diastolic blood pres-
sure, and from -3.6 to -17.8 mmHg for systolic blood pres-
sure.
Intervention trials have been less consistent [24-37].
Many of the studies that failed to find a treatment effect
have had design limitations such as no control group or
no placebo control, short duration, small sample size,
concomitant use of non-study dietary supplements con-
taining vitamin C, and varying or inadequately described
methods for measuring BP; or they were post-hoc analyses
where change in BP was not a primary endpoint of the
trial. On the other hand, some studies have found signifi-
cant reductions in BP as a result of treatment with vitamin
C [38-41].
The DASH study [3] is the major intervention trial of
nutritional factors, and our results are comparable in mag-
nitude to those of DASH. Among all participants in the
DASH study, the DASH diet lowered mean systolic BP by
5.5 mmHg, and lowered mean diastolic BP by 3.0 mmHg.
In the present study, the difference between the mean BP
in the first and fourth quartiles of ascorbic acid concentra-
tion was 4.7 mmHg systolic, and 6.1 mmHg diastolic BP.
This suggests the possibility that if the ascorbic acid con-
centration of those in the lower one-fourth of the distribu-
tion could be increased to the ascorbic acid concentration
of those in the top one-fourth of the distribution, an effect
comparable to that of the DASH diet could be achieved.
The present study was not an intervention study and such
an intervention effect is only a hypothesis, but one which
would seem to merit follow-up.
The ranges of plasma ascorbic acid seen in our sample are
very consistent with those found in the United States. We
examined data from the National Health and Nutrition
Examination Survey (NHANES) 2003–2004, among
Systolic blood pressure by quartiles of plasma ascorbic acid, NHLBI Growth and Health Study, Richmond, CA cohort, 1996–1997 (tests for linear trend: nadjusted p = 0.0001; adjusted for race, BMI, education, dietary fat, dietary sodium, p = 0.005)Figure 1
Systolic blood pressure by quartiles of plasma ascorbic acid, NHLBI Growth and Health Study, Richmond, CA cohort, 1996–
1997 (tests for linear trend: unadjusted p = 0.0001; adjusted for race, BMI, education, dietary fat, dietary sodium, p = 0.005). 
Plasma ascorbic acid concentrations by quartile: Q1, 0.59 mg/dL (SD 0.18); Q2, 1.03 mg/dL (SD 0.10); Q3, 1.36 mg/dL (SD 
0.10); Q4, 1.83 mg/dL (SD 0.34). (SI units: 33.51 μmol/L, 58.50 μmol/L, 77.25 μmol/L, 103.94 μmol/L)
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plasma ascorbic acid concentrations in the four quartiles
were 0.43 mg/dL, 0.84 mg/dL, 1.14 mg/dL, and 1.59 mg/
dL (24.1, 47.8, 64.8, 90.1 μmol/L). (Block, unpublished
data.) In our sample those means were 0.59, 1.03, 1.36
and 1.83 mg/dL. Thus, in the present sample the first three
quartiles were similar although slightly higher than those
seen in representative national data. The lower two quar-
tiles represent ascorbic acid concentrations most likely
obtained from fruits, vegetables and fortified foods such
as cereals. A diet rich in fruits and vegetables can produce
a concentration similar to that seen in the third quartile.
The concentration in the fourth quartile represents a level
in which supplements containing vitamin C have made a
substantial contribution.
There is substantial biologic rationale for a causal role of
ascorbic acid in maintaining normal BP. Numerous oxi-
dative mechanisms appear to be involved in the patho-
genesis of hypertension [6,7,42]. One well-studied
oxidative stress biomarker is F2-isoprostane, a vasoactive
product of lipid peroxidation [43]; we have shown in a
randomized trial that supplementation with vitamin C,
but not with vitamin E, significantly reduces F2-isopros-
tane [44]. Similarly inflammation, consistently associated
with increased risk of cardiovascular disease, is associated
with impaired endothelium-dependent vasodilation and
hypertension [45]. Bautista found a progressive increase
in blood pressure with increases in high-sensitivity C-reac-
tive protein (hsCRP), a sensitive marker of inflammation
[45]. We showed, in a randomized trial, that vitamin C
but not vitamin E significantly lowered hsCRP, to an
extent equivalent to that seen with statins [46]. Thus, vita-
min C may have a beneficial effect on BP by mitigating the
adverse effects of inflammation and oxidative stress. Spe-
cific functions of vitamin C have also been shown. These
include effects on smooth muscle contractility of periph-
eral blood vessels and improvement of vasomotor dys-
function [47], prevention of nitric oxide inhibition of
release of endothelium-derived relaxing factor [48], and
prevention of free radical inhibition of prostacyclin syn-
thetase. Ascorbic acid may also influence BP by maintain-
Diastolic blood pressure by quartiles of plasma ascorbic acid, NHLBI Growth and Health Study, Richmond, CA cohort, 1996–1997 (tests f r lin ar t nd: un djusted  = 0.0001; adjuste  for race, BMI, education, dietary fat, dietary sodium, p = 0.0002)Figure 2
Diastolic blood pressure by quartiles of plasma ascorbic acid, NHLBI Growth and Health Study, Richmond, CA cohort, 1996–
1997 (tests for linear trend: unadjusted p = 0.0001; adjusted for race, BMI, education, dietary fat, dietary sodium, p = 0.0002). 
Plasma ascorbic acid concentrations by quartile: Q1, 0.59 mg/dL (SD 0.18); Q2, 1.03 mg/dL (SD 0.10); Q3, 1.36 mg/dL (SD 
0.10); Q4, 1.83 mg/dL (SD 0.34). (SI units: 33.51 μmol/L, 58.50 μmol/L, 77.25 μmol/L, 103.94 μmol/L)
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oxide through enhanced recycling of tetrahydrobiopterin,
a cofactor that stabilizes and sustains the activity of
endothelial nitric oxide synthase [49-52].
An important limitation of this study is the fact that the
results depicted in Figures 1 and 2 are cross-sectional and
therefore causality cannot be inferred. Also, the data rep-
resented in Figure 3 are limited by the fact that there were
no plasma ascorbic acid measurements for the 9th annual
visit, and therefore the association with change in BP,
while longitudinal, is not truly prospective. In interpreting
our findings it is important to consider the fact that die-
tary variables are often correlated with one another and
may be correlated with lifestyle variables. Therefore, it is
possible that plasma ascorbic acid concentration is simply
a marker for another variable that influences BP. How-
ever, the association persisted even after controlling for
BMI, race, education, and intake of fat, sodium and anti-
oxidants. We also evaluated the effect of controlling for
other potential confounders including smoking, alcohol
consumption, television or video watching, and intake of
total energy, calcium, and potassium, and none dimin-
ished the strength of the association.
Nevertheless, while we cannot confidently infer causality,
our findings point to the important possibility that vita-
min C may influence BP even among healthy young
adults. This finding is of importance because lowering BP
or attenuating increases in BP in young adults may lead to
lower BP in older adults, which in turn may reduce the
risk of age-associated vascular events. Therefore, our find-
ings suggest that further study of the relationship between
vitamin C and BP in this young-adult population is war-
ranted.
Conclusion
This is the first study to report on the relationship between
plasma ascorbic acid concentration and BP in a cohort of
young, normotensive women, aged 18–21 years. Plasma
Change in blood pressure between visit 9 and visit 10, by quartiles of plasma ascorbic acid at visit 10, NHLBI Growth and He lth Study, Richmond, CA cohort, 1996–1997 ( ests for linear trend: systolic BP p = 0.005; diastolic BP p < 0.0001; adjusted for race, BMI, e ucation dietary fat, dietary sod um)Figur 3
Change in blood pressure between visit 9 and visit 10, by quartiles of plasma ascorbic acid at visit 10, NHLBI Growth and 
Health Study, Richmond, CA cohort, 1996–1997 (tests for linear trend: systolic BP p = 0.005; diastolic BP p < 0.0001; adjusted 
for race, BMI, education, dietary fat, dietary sodium). Plasma ascorbic acid concentrations by quartile: Q1, 0.59 mg/dL (SD 
0.18); Q2, 1.03 mg/dL (SD 0.10); Q3, 1.36 mg/dL (SD 0.10); Q4, 1.83 mg/dL (SD 0.34). (SI units: 33.51 μmol/L, 58.50 μmol/L, 
77.25 μmol/L, 103.94 μmol/L)
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Nutrition Journal 2008, 7:35 http://www.nutritionj.com/content/7/1/35ascorbic acid concentration was found to be inversely
associated with BP and with change in BP over the previ-
ous year. These inverse relationships were observed in a
sample where two-thirds of participants were Black, a
population that suffers disproportionately from elevated
BP and its sequelae. Lowering BP or attenuating increases
in BP in healthy young adults may lead to lower BP in
older adults and reduced risk of age-associated vascular
events. This study suggests that vitamin C may be an
important factor in BP regulation even among health
young adults, and that further study is warranted.
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